Patient Information Leaflets

You can also view Patient Information Leaflets by A-Z.

Leaflets can be translated on-demand by pressing the 'Accessibility' button at the top of this page, and then choose 'Translate this page'. Alternatively you can request leaflets in another language or format by contacting our Patient and Family Experience Team.

  • Botulinum Toxin for Chronic Migraines

    The toxin is a protein and is produced by a bacterium called Clostridium Botulinum.

  • Erenumab (Aimovig®)

    Erenumab (Aimovig®) is a monoclonal antibody treatment which is now available on the NHS as a treatment option for preventing migraine in people who have four or more migraine days a month and have tried at least three other preventative medications that have not worked.

  • Fremanezumab (Ajovy®)

    Fremanezumab (Ajovy®) is a monoclonal antibody therapy that has been approved for treatment of chronic migraine.

  • Galcanezumab (Emgality®)

    Galcanezumab (Emgality®) is a monoclonal antibody treatment which is now available on the NHS as a possible treatment for preventing migraine in people who:

    • have four or more migraine days a month
    • have tried at least three other preventative medications which have not worked
    • have completed three months of headache diaries (including HIT-6)
    • lifestyle modifications (medication and caffeine use) have been addressed

  • Migraine - a comprehensive guide

    There are many different types of headache, migraine, cluster headaches, sinus headache, and more. However, more than 90% of headaches will be caused by migraine – this booklet will help you to identify if your headaches are due to migraine and if so, how best to stop them happening.

Related content

Pages